No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1djwB2, 1.0000, 0.00, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-12-CYCLIC- MONOPHOSPHONATE
2, d1djzB2, 0.9983, 0.17, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-45-BISPHOSPHATE
3, d1isdA3, 0.9923, 0.40, 1.000, 131, 131,  
4, d2isdB2, 0.9883, 0.54, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT
5, d1djhA2, 0.9828, 0.77, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH BARIUM
6, d1djwA2, 0.9826, 0.71, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-2-METHYLENE-12-CYCLIC- MONOPHOSPHONATE
7, d1djzA2, 0.9817, 0.71, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-45-BISPHOSPHATE
8, d1djyA2, 0.9810, 0.73, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-245-TRISPHOSPHATE
9, d1djyB2, 0.9805, 0.83, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-245-TRISPHOSPHATE
10, d1djiA2, 0.9802, 0.88, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM
11, d1djxB2, 0.9800, 0.92, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-145-TRISPHOSPHATE
12, d1djxA2, 0.9799, 0.86, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH INOSITOL-145-TRISPHOSPHATE
13, d1djgA2, 0.9798, 0.88, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH LANTHANUM
14, d2isdA2, 0.9797, 0.88, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT
15, d1djgB2, 0.9790, 0.91, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH LANTHANUM
16, d1djhB2, 0.9787, 0.88, 1.000, 131, 131, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH BARIUM
17, d1djiB2, 0.9780, 0.38, 1.000, 129, 129, PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT COMPLEXED WITH CALCIUM
18, d1qatA2, 0.9604, 0.40, 1.000, 129, 129, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA COMPLEX WITH SAMARIUM (III) CHLORIDE
19, d1qatB2, 0.9602, 1.12, 1.000, 131, 131, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA COMPLEX WITH SAMARIUM (III) CHLORIDE
20, d1qasB2, 0.9516, 1.20, 1.000, 131, 131, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1
21, d1qasA2, 0.9487, 0.49, 1.000, 126, 126, 1-PHOSPHATIDYLINOSITOL-45-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1
22, p3qr1A2, 0.8609, 0.55, 0.992, 126, 126, CRYSTAL STRUCTURE OF L. PEALEI PLC21
23, p3qr1D3, 0.8608, 1.29, 0.322, 162, 121, CRYSTAL STRUCTURE OF L. PEALEI PLC21
24, p3qr0A2, 0.8597, 1.29, 0.322, 162, 121, CRYSTAL STRUCTURE OF S. OFFICINALIS PLC21
25, p4qj4B2, 0.8565, 1.29, 0.322, 161, 121, STRUCTURE OF A FRAGMENT OF HUMAN PHOSPHOLIPASE C-BETA3 DELTA472-569 BOUND TO IP3 AND IN COMPLEX WITH GALPHAQ
26, p4qj3B2, 0.8538, 1.31, 0.347, 134, 121, STRUCTURE OF A FRAGMENT OF HUMAN PHOSPHOLIPASE C-BETA3 DELTA472-559 IN COMPLEX WITH GALPHAQ
27, p4gnkD5, 0.8514, 1.29, 0.298, 180, 121, CRYSTAL STRUCTURE OF GALPHAQ IN COMPLEX WITH FULL-LENGTH HUMAN PLCBETA3
28, p4gnkB2, 0.8513, 1.33, 0.298, 180, 121, CRYSTAL STRUCTURE OF GALPHAQ IN COMPLEX WITH FULL-LENGTH HUMAN PLCBETA3
29, p3ohmB2, 0.8510, 1.33, 0.298, 180, 121, CRYSTAL STRUCTURE OF ACTIVATED G ALPHA Q BOUND TO ITS EFFECTOR PHOSPHOLIPASE C BETA 3
30, p4qj5B2, 0.8492, 1.36, 0.298, 134, 121, STRUCTURE OF A FRAGMENT OF HUMAN PHOSPHOLIPASE C-BETA3 DELTA472-581 BOUND TO IP3 AND IN COMPLEX WITH GALPHAQ
31, d2zkmX2, 0.8340, 1.36, 0.298, 143, 121, CRYSTAL STRUCTURE OF PHOSPHOLIPASE C BETA 2
32, d2fjuB2, 0.8298, 1.36, 0.298, 142, 121, ACTIVATED RAC1 BOUND TO ITS EFFECTOR PHOSPHOLIPASE C BETA 2
33, d3kwuA1, 0.8233, 1.38, 0.298, 180, 121, MUNC13-1 C2B-DOMAIN CALCIUM BOUND
34, d2nsqA_, 0.8094, 1.32, 0.339, 122, 118, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE HUMAN E3 UBIQUITIN-PROTEIN LIGASE NEDD4-LIKE PROTEIN
35, p3pycA_, 0.8026, 1.36, 0.339, 122, 118, CRYSTAL STRUCTURE OF HUMAN SMURF1 C2 DOMAIN
36, p3jzyA_, 0.7996, 1.92, 0.242, 133, 120, CRYSTAL STRUCTURE OF HUMAN INTERSECTIN 2 C2 DOMAIN
37, p5iz5B1, 0.7995, 1.92, 0.242, 133, 120, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2
38, d2fk9A1, 0.7956, 2.42, 0.279, 140, 122, HUMAN PROTEIN KINASE C ETA
39, d3kwtA_, 0.7951, 2.37, 0.172, 132, 122, MUNC13-1 C2B-DOMAIN CALCIUM-FREE
40, d1gmiA_, 0.7948, 2.37, 0.172, 132, 122, STRUCTURE OF THE C2 DOMAIN FROM NOVEL PROTEIN KINASE C EPSILON
41, p4ihbE_, 0.7942, 1.65, 0.233, 124, 116, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
42, d2ep6A1, 0.7939, 1.65, 0.233, 124, 116, SOLUTION STRUCTURE OF THE SECOND C2 DOMAIN FROM HUMAN MCTP2 PROTEIN
43, d1rlwA_, 0.7939, 2.01, 0.175, 128, 120, CALCIUM-PHOSPHOLIPID BINDING DOMAIN FROM CYTOSOLIC PHOSPHOLIPASE A2
44, p3l4cB_, 0.7904, 1.83, 0.216, 139, 116, STRUCTURAL BASIS OF MEMBRANE-TARGETING BY DOCK180
45, p3l4cA_, 0.7903, 1.83, 0.216, 139, 116, STRUCTURAL BASIS OF MEMBRANE-TARGETING BY DOCK180
46, p4p42B3, 0.7889, 1.52, 0.239, 116, 113, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
47, d1cjyB1, 0.7888, 2.03, 0.188, 135, 117, HUMAN CYTOSOLIC PHOSPHOLIPASE A2
48, p4npkA1, 0.7883, 1.86, 0.229, 126, 118, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS CALCIUM BOUND
49, p4iqhB_, 0.7864, 2.03, 0.215, 126, 121, CRYSTAL STRUCTURE ANALYSIS OF DYSFERLIN C2A VARIANT 1 (C2AV1)
50, d1cjyA1, 0.7864, 2.03, 0.215, 126, 121, HUMAN CYTOSOLIC PHOSPHOLIPASE A2
51, p5izrB1, 0.7860, 2.07, 0.160, 126, 119, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
52, p5ixcA1, 0.7845, 2.23, 0.107, 179, 122, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE
53, p5ixcB1, 0.7839, 2.23, 0.107, 179, 122, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE
54, p4npkA2, 0.7819, 2.26, 0.106, 178, 123, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS CALCIUM BOUND
55, p4iqhA_, 0.7798, 2.17, 0.190, 146, 116, CRYSTAL STRUCTURE ANALYSIS OF DYSFERLIN C2A VARIANT 1 (C2AV1)
56, p4p42A3, 0.7795, 2.22, 0.167, 127, 120, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
57, d2nq3A1, 0.7782, 1.97, 0.214, 127, 117, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN ITCHY HOMOLOG E3 UBIQUITIN PROTEIN LIGASE
58, p4iqhC_, 0.7773, 2.15, 0.227, 127, 119, CRYSTAL STRUCTURE ANALYSIS OF DYSFERLIN C2A VARIANT 1 (C2AV1)
59, p4ihbB_, 0.7773, 2.25, 0.158, 129, 120, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
60, p5izrA1, 0.7761, 2.25, 0.158, 129, 120, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
61, p4ihbC_, 0.7753, 1.83, 0.190, 125, 116, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
62, p4npjA2, 0.7743, 1.80, 0.183, 124, 115, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
63, p5iz5A1, 0.7741, 1.80, 0.183, 124, 115, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2
64, p4npjB2, 0.7741, 1.62, 0.196, 142, 112, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
65, p4npjA1, 0.7733, 2.25, 0.227, 128, 119, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
66, p4ihbD_, 0.7716, 1.76, 0.195, 140, 113, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
67, d3b7yB_, 0.7716, 2.11, 0.153, 131, 118, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE E3 UBIQUITIN- PROTEIN LIGASE NEDD4
68, p4ihbA_, 0.7710, 2.11, 0.153, 131, 118, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
69, p5izrD1, 0.7706, 2.26, 0.218, 128, 119, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
70, d3b7yA_, 0.7700, 2.05, 0.229, 126, 118, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE E3 UBIQUITIN- PROTEIN LIGASE NEDD4
71, p5a50B_, 0.7687, 1.85, 0.191, 124, 115, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS ZN AND PHOPHO CHOLINE
72, p5a51B_, 0.7677, 2.12, 0.229, 127, 118, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND PHOPHATIDYL SERINE
73, p4v29B_, 0.7674, 2.23, 0.214, 128, 117, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS
74, p4ihbF_, 0.7671, 2.23, 0.214, 128, 117, X-RAY STRUCTURE OF THE CANONICAL C2A DOMAIN FROM HUMAN DYSFERLIN
75, p5izrC1, 0.7661, 1.92, 0.174, 139, 115, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2 IN COMPLEX WITH METHYL GAMMA- LINOLENYL FLUOROPHOSPHONATE INHIBITOR AND TERBIUM CHLORIDE
76, p5a51A_, 0.7657, 1.92, 0.174, 139, 115, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND PHOPHATIDYL SERINE
77, p3m7fB_, 0.7656, 1.87, 0.219, 121, 114, CRYSTAL STRUCTURE OF THE NEDD4 C2/GRB10 SH2 COMPLEX
78, p2dmhA_, 0.7654, 1.78, 0.187, 149, 112, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN OF HUMAN MYOFERLIN
79, p5a4xB_, 0.7648, 1.78, 0.187, 149, 112, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND ZN
80, d2cjsA1, 0.7644, 2.13, 0.229, 128, 118, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
81, p4v29A_, 0.7639, 2.13, 0.229, 128, 118, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS
82, p4rj9A_, 0.7637, 3.11, 0.270, 146, 126, STRUCTURE OF A PLANT SPECIFIC C2 DOMAIN PROTEIN OSGAP1 FROM RICE
83, p4p42A2, 0.7637, 3.11, 0.270, 146, 126, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
84, p3l9bA_, 0.7637, 2.14, 0.229, 126, 118, CRYSTAL STRUCTURE OF RAT OTOFERLIN C2A
85, p2jqzA_, 0.7632, 1.85, 0.175, 137, 114, SOLUTION STRUCTURE OF THE C2 DOMAIN OF HUMAN SMURF2
86, d2cjsB2, 0.7631, 2.81, 0.277, 144, 119, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
87, p5a50A_, 0.7628, 2.12, 0.241, 165, 116, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS ZN AND PHOPHO CHOLINE
88, p4npjB1, 0.7627, 2.08, 0.250, 165, 116, EXTENDED-SYNAPTOTAGMIN 2 C2A- AND C2B-DOMAINS
89, p5a52A_, 0.7618, 2.10, 0.250, 165, 116, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR1 IN COMPLEX WITH ONE CALCIUM ION
90, p5a4xA_, 0.7618, 2.22, 0.229, 126, 118, THE CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA CAR4 IN COMPLEX WITH TWO CALCIUM IONS AND ZN
91, d2cjtD_, 0.7563, 1.83, 0.177, 122, 113, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
92, p4zopA4, 0.7546, 2.14, 0.241, 165, 116, CO-CRYSTAL STRUCTURE OF LIPID KINASE PI3K ALPHA WITH A SELECTIVE PHOSPHATIDYLINOSITOL-3 KINASE ALPHA INHIBITOR
93, p5fi4A5, 0.7539, 2.79, 0.269, 135, 119, DISCOVERY OF IMIDAZO[12-A]-PYRIDINE INHIBITORS OF PAN-PI3 KINASES THAT ARE EFFICACIOUS IN A MOUSE XENOGRAFT MODEL
94, p5xgiA3, 0.7535, 2.20, 0.254, 140, 118, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
95, d2cjtC_, 0.7535, 2.20, 0.254, 140, 118, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
96, p4wafA4, 0.7532, 2.14, 0.250, 163, 116, CRYSTAL STRUCTURE OF A NOVEL TETRAHYDROPYRAZOLO[15-A]PYRAZINE IN AN ENGINEERED PI3K ALPHA
97, p4jpsA6, 0.7529, 2.20, 0.158, 150, 114, CO-CRYSTAL STRUCTURES OF THE LIPID KINASE PI3K ALPHA WITH PAN AND ISOFORM SELECTIVE INHIBITORS
98, p5vlrA2, 0.7521, 2.16, 0.241, 165, 116, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A TRIFLUORO-ETHYL- PYRAZOL-PYROLOTRIAZINE INHIBITOR
99, p5uk8A3, 0.7519, 2.16, 0.241, 165, 116, THE CO-STRUCTURE OF (R)-4-(6-(1-(CYCLOPROPYLSULFONYL)CYCLOPROPYL)-2- (1H-INDOL-4-YL)PYRIMIDIN-4-YL)-3-METHYLMORPHOLINE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
100, p5ue8A2, 0.7518, 2.01, 0.237, 161, 114, THE CRYSTAL STRUCTURE OF MUNC13-1 C1C2BMUN DOMAIN
101, d1bciA_, 0.7518, 2.38, 0.214, 127, 117, C2 DOMAIN OF CYTOSOLIC PHOSPHOLIPASE A2 NMR MINIMIZED AVERAGE STRUCTURE
102, p4l1bA5, 0.7515, 2.08, 0.172, 126, 116, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA
103, p5itdA4, 0.7513, 2.08, 0.172, 126, 116, CRYSTAL STRUCTURE OF PI3K ALPHA WITH PI3K DELTA INHIBITOR
104, p5ul1A4, 0.7503, 2.72, 0.197, 131, 122, THE CO-STRUCTURE OF 3-AMINO-6-(4-((1-(DIMETHYLAMINO)PROPAN-2-YL) SULFONYL)PHENYL)-N-PHENYLPYRAZINE-2-CARBOXAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
105, p5ukjA4, 0.7502, 2.21, 0.158, 155, 114, THE CO-STRUCTURE OF NN-DIMETHYL-4-[(6R)-6-METHYL-5-(1H-PYRROLO[23- B]PYRIDIN-4-YL)-4567-TETRAHYDROPYRAZOLO[15- A]PYRAZIN-3- YL]BENZENESULFONAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT THAT MIMICS ATR
106, p4l23A3, 0.7500, 2.21, 0.158, 155, 114, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND PI-103
107, p5xghA4, 0.7489, 2.17, 0.241, 165, 116, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
108, p2enqA_, 0.7479, 1.72, 0.191, 147, 110, SOLUTION STRUCTURE OF THE C2 DOMAIN FROM HUMAN PI3-KINASE P110 SUBUNIT ALPHA
109, p3nsjA2, 0.7447, 1.94, 0.212, 154, 113, THE X-RAY CRYSTAL STRUCTURE OF LYMPHOCYTE PERFORIN
110, p5ubtA3, 0.7446, 2.18, 0.250, 158, 116, CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1- YL)PHENYL)PYRROLO[21-F][124] TRIAZIN-4-AMINE DERIVIATINE
111, d2cjtB_, 0.7441, 2.14, 0.161, 127, 112, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
112, p4l2yA4, 0.7438, 3.14, 0.159, 160, 126, CRYSTAL STRUCTURE OF P110ALPHA COMPLEXED WITH NISH2 OF P85ALPHA AND COMPOUND 9D
113, d2yoaB_, 0.7430, 3.16, 0.159, 160, 126, SYNAPTOTAGMIN-1 C2B DOMAIN WITH PHOSPHOSERINE
114, p5vfgA_, 0.7429, 3.17, 0.159, 158, 126, SYNAPTOTAGMIN 1 C2B DOMAIN; LEAD-BOUND (HIGH OCCUPANCY) 
115, d5ccjB_, 0.7412, 2.21, 0.170, 127, 112, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
116, p5t8fA3, 0.7406, 3.16, 0.159, 160, 126, P110DELTA/P85ALPHA WITH TASELISIB (GDC-0032)
117, d1uovA1, 0.7400, 3.10, 0.159, 160, 126, CALCIUM BINDING DOMAIN C2B
118, d5ccjA_, 0.7392, 2.88, 0.154, 158, 123, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
119, p5dxuA3, 0.7391, 3.16, 0.159, 160, 126, P110DELTA/P85ALPHA WITH GDC-0326
120, d5ccjC_, 0.7390, 1.37, 0.245, 107, 106, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
121, d2yoaA1, 0.7389, 2.49, 0.150, 123, 120, SYNAPTOTAGMIN-1 C2B DOMAIN WITH PHOSPHOSERINE
122, d1uowA1, 0.7384, 3.20, 0.159, 157, 126, CALCIUM BINDING DOMAIN C2B
123, d1tjxA1, 0.7384, 3.16, 0.159, 161, 126, CRYSTALLOGRAPHIC IDENTIFICATION OF CA2+ COORDINATION SITES IN SYNAPTOTAGMIN I C2B DOMAIN
124, d5ccjD1, 0.7378, 3.16, 0.159, 161, 126, CRYSTAL STRUCTURE OF THE QUINTUPLE MUTANT OF THE SYNAPTOTAGMIN-1 C2B DOMAIN
125, p5ccgE2, 0.7373, 3.18, 0.159, 160, 126, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
126, p5xgjA5, 0.7371, 3.18, 0.159, 160, 126, CRYSTAL STRUCTURE OF PI3K COMPLEX WITH AN INHIBITOR 
127, p4yknA7, 0.7369, 3.20, 0.159, 157, 126, PI3K ALPHA LIPID KINASE WITH ACTIVE SITE INHIBITOR
128, d1tjmA1, 0.7369, 3.22, 0.159, 157, 126, CRYSTALLOGRAPHIC IDENTIFICATION OF SR2+ COORDINATION SITE IN SYNAPTOTAGMIN I C2B DOMAIN
129, p5kj7E2, 0.7367, 3.11, 0.152, 158, 125, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
130, p4y1tA_, 0.7367, 2.10, 0.195, 167, 113, STRUCTURAL BASIS FOR CA2+-MEDIATED INTERACTION OF THE PERFORIN C2 DOMAIN WITH LIPID MEMBRANES
131, p5kj8K2, 0.7364, 2.10, 0.195, 167, 113, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
132, d2r83B1, 0.7361, 3.01, 0.154, 400, 123, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
133, d2r83A1, 0.7360, 2.25, 0.153, 121, 111, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
134, p5vffA_, 0.7350, 3.01, 0.164, 146, 122, SYNAPTOTAGMIN 1 C2B DOMAIN; LEAD-BOUND (LOW OCCUPANCY) 
135, p5kj8E2, 0.7348, 2.45, 0.250, 149, 112, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
136, p6eyzA5, 0.7344, 2.58, 0.259, 151, 112, PI3 KINASE DELTA IN COMPLEX WITH 4-FLUOROPHENYL 5-(4-(5-((4- ISOPROPYLPIPERAZIN-1-YL)METHYL)OXAZOL-2-YL)-1H-INDAZOL-6-YL)-2- METHOXYNICOTINATE
137, p5kj7K2, 0.7344, 2.60, 0.250, 151, 112, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
138, d2cjtA1, 0.7340, 2.99, 0.164, 385, 122, STRUCTURAL BASIS FOR A MUNC13-1 DIMERIC   - MUNC13-1 - RIM HETERODIMER SWITCH: C2-DOMAINS AS VERSATILE PROTEIN- PROTEIN INTERACTION MODULES
139, p2qz5A_, 0.7339, 2.66, 0.250, 148, 112, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF AIDA
140, p5ccgK2, 0.7338, 2.58, 0.250, 148, 112, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
141, p4v11A_, 0.7338, 3.00, 0.164, 383, 122, STRUCTURE OF SYNAPTOTAGMIN-1 WITH SV2A PEPTIDE PHOSPHORYLATED AT THR84
142, p4ovuA3, 0.7335, 2.55, 0.250, 148, 112, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH NISH2 OF P85ALPHA
143, p2qz5B_, 0.7327, 2.56, 0.259, 148, 112, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF AIDA
144, p5l72A2, 0.7322, 2.67, 0.250, 148, 112, PI3 KINASE DELTA IN COMPLEX WITH N-[6-(5-METHANESULFONAMIDO-6- METHOXYPYRIDIN-3-YL)-13-DIHYDRO-2-BENZOFURAN-4-YL]-2-(MORPHOLIN-4- YL)ACETAMIDE
145, p5dxhA6, 0.7321, 2.67, 0.250, 148, 112, P110ALPHA/P85ALPHA WITH COMPOUND 5
146, d1dsyA_, 0.7320, 2.63, 0.250, 151, 112, C2 DOMAIN FROM PROTEIN KINASE C (ALPHA) COMPLEXED WITH CA2+ AND PHOSPHATIDYLSERINE
147, d2uzpA_, 0.7314, 2.63, 0.250, 149, 112, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN PROTEIN KINASE C GAMMA.
148, p6ewpA_, 0.7304, 2.91, 0.167, 144, 120, MUS MUSCULUS CEP120 THIRD C2 DOMAIN (C2C) 
149, d4l1lA_, 0.7301, 2.75, 0.160, 144, 119, RAT PKC C2 DOMAIN BOUND TO CD
150, d6ankB2, 0.7298, 2.68, 0.250, 148, 112, SYNAPTOTAGMIN-7 C2A- AND C2B-DOMAINS
151, d2uzpB_, 0.7298, 2.68, 0.250, 149, 112, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN PROTEIN KINASE C GAMMA.
152, p5ug7A_, 0.7294, 2.12, 0.204, 126, 113, CALCIUM BOUND PERFORIN C2 DOMAIN - T431D
153, p5swgA5, 0.7292, 2.65, 0.250, 149, 112, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 5 AND 21
154, p6ewpC_, 0.7289, 2.60, 0.250, 151, 112, MUS MUSCULUS CEP120 THIRD C2 DOMAIN (C2C) 
155, d2uzpC_, 0.7286, 2.60, 0.250, 151, 112, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF HUMAN PROTEIN KINASE C GAMMA.
156, p5cciE2, 0.7282, 2.50, 0.264, 149, 110, STRUCTURE OF THE MG2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
157, p5cchE2, 0.7281, 2.67, 0.250, 149, 112, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
158, d3rdjA_, 0.7281, 2.89, 0.150, 148, 120, RAT PKC C2 DOMAIN APO
159, d3twyA_, 0.7279, 2.68, 0.250, 149, 112, RAT PKC C2 DOMAIN BOUND TO PB
160, d3rdlA_, 0.7279, 2.25, 0.156, 118, 109,  
161, p4tv3A2, 0.7276, 3.07, 0.153, 152, 124, ISOLATED P110A SUBUNIT OF PI3KA PROVIDES A PLATFORM FOR STRUCTURE- BASED DRUG DESIGN
162, d3gpeA_, 0.7276, 2.68, 0.250, 149, 112, CRYSTAL STRUCTURE ANALYSIS OF PKC (ALPHA)-C2 DOMAIN COMPLEXED WITH CA2+ AND PTDINS(45)P2
163, d3n5aA_, 0.7272, 2.69, 0.259, 150, 112, SYNAPTOTAGMIN-7 C2B-DOMAIN CALCIUM BOUND
164, p4qamB_, 0.7268, 3.24, 0.160, 154, 125, CRYSTAL STRUCTURE OF THE RPGR RCC1-LIKE DOMAIN IN COMPLEX WITH THE RPGR-INTERACTING DOMAIN OF RPGRIP1
165, p5swoA5, 0.7267, 2.97, 0.154, 154, 123, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 4 AND 19
166, p4ovvA3, 0.7265, 2.97, 0.154, 154, 123, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH DIC4-PIP2
167, d1a25A_, 0.7263, 2.92, 0.150, 148, 120, C2 DOMAIN FROM PROTEIN KINASE C (BETA)
168, d4ldcA1, 0.7257, 3.15, 0.154, 153, 123, CRYSTAL STRUCTURE OF DOC2B C2B DOMAIN
169, d6ankA2, 0.7256, 2.81, 0.202, 137, 114, SYNAPTOTAGMIN-7 C2A- AND C2B-DOMAINS
170, p5swpA5, 0.7255, 3.09, 0.198, 141, 116, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 6 AND 24
171, p4tuuA2, 0.7253, 3.09, 0.198, 141, 116, ISOLATED P110A SUBUNIT OF PI3KA PROVIDES A PLATFORM FOR STRUCTURE- BASED DRUG DESIGN
172, d1a25B_, 0.7252, 2.80, 0.129, 166, 124, C2 DOMAIN FROM PROTEIN KINASE C (BETA)
173, d1wfjA1, 0.7248, 2.91, 0.211, 138, 114, C2 DOMAIN-CONTAINING PROTEIN FROM PUTATIVE ELICITOR- RESPONSIVE GENE
174, d1e7uA2, 0.7247, 2.31, 0.222, 138, 108, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
175, p2qzqA_, 0.7245, 2.95, 0.200, 141, 115, CRYSTAL STRUCTURE OF C-TERMINAL OF AIDA
176, p5swtA5, 0.7241, 2.21, 0.204, 126, 113, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 17 AND 27
177, p5sxkA5, 0.7239, 3.21, 0.161, 153, 124, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 18
178, p6ewpB_, 0.7233, 2.89, 0.129, 167, 124, MUS MUSCULUS CEP120 THIRD C2 DOMAIN (C2C) 
179, p5t2lA1, 0.7232, 3.12, 0.198, 141, 116, MPI3KD IN COMPLEX WITH 7L
180, p5swrA5, 0.7232, 2.75, 0.250, 152, 112, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 20 AND 26
181, p2wxgA1, 0.7232, 2.73, 0.250, 152, 112, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW13.
182, p3pfqA3, 0.7220, 2.73, 0.250, 152, 112, CRYSTAL STRUCTURE AND ALLOSTERIC ACTIVATION OF PROTEIN KINASE C BETA II
183, d1k5wA_, 0.7219, 2.55, 0.214, 137, 112, THREE-DIMENSIONAL STRUCTURE OF THE SYNAPTOTAGMIN 1 C2B- DOMAIN: SYNAPTOTAGMIN 1 AS A PHOSPHOLIPID BINDING MACHINE
184, p5t28A1, 0.7218, 2.61, 0.214, 137, 112, MPI3KD IN COMPLEX WITH 5K
185, p2x38A1, 0.7218, 2.61, 0.214, 137, 112, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH IC87114.
186, p5sxaA6, 0.7217, 3.02, 0.143, 148, 119, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 10
187, d5lowC_, 0.7217, 2.90, 0.202, 137, 114, STRUCTURE OF THE CA2+-BOUND RABPHILIN 3A C2B DOMAIN SNAP25 COMPLEX (P21 SPACE GROUP)
188, d5t0sA_, 0.7216, 2.26, 0.222, 138, 108, SYNAPTOTAGMIN 1 C2B DOMAIN CADMIUM-BOUND
189, p5sxbA5, 0.7216, 2.26, 0.222, 138, 108, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 23
190, p5ue8B4, 0.7212, 2.60, 0.109, 164, 119, THE CRYSTAL STRUCTURE OF MUNC13-1 C1C2BMUN DOMAIN
191, p2wxlA1, 0.7211, 2.60, 0.109, 164, 119, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH ZSTK474.
192, p2wxfA1, 0.7208, 3.17, 0.161, 153, 124, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH PIK-39.
193, d5t0rA_, 0.7207, 3.24, 0.163, 152, 123, SYNAPTOTAGMIN 1 C2A DOMAIN CADMIUM-BOUND
194, d1rsyA1, 0.7206, 2.59, 0.234, 132, 111, STRUCTURE OF THE FIRST C2-DOMAIN OF SYNAPTOTAGMIN I: A NOVEL CA2+(SLASH)PHOSPHOLIPID BINDING FOLD
195, d5w5cF2, 0.7203, 2.45, 0.255, 148, 110, CRYSTAL STRUCTURE OF THE PRIMED SNARE-COMPLEXIN-SYNAPTOTAGMIN-1 C2AB COMPLEX
196, d2n1tE1, 0.7203, 2.28, 0.224, 137, 107, DYNAMIC BINDING MODE OF A SYNAPTOTAGMIN-1-SNARE COMPLEX IN SOLUTION
197, p2wxiA1, 0.7200, 3.18, 0.161, 153, 124, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW30.
198, d1bynA_, 0.7197, 3.04, 0.143, 148, 119, SOLUTION STRUCTURE OF THE CALCIUM-BOUND FIRST C2-DOMAIN OF SYNAPTOTAGMIN I
199, p2wxkA1, 0.7196, 2.40, 0.236, 132, 110, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH INK666.
200, p5kj8F2, 0.7195, 2.55, 0.209, 123, 115, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
201, p5ccgF2, 0.7192, 2.55, 0.209, 123, 115, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
202, p5kj7F2, 0.7191, 3.13, 0.140, 149, 121, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
203, p5ngbA1, 0.7190, 3.13, 0.140, 149, 121, X-RAY DIFFRACTION CRYSTAL STRUCTURE OF THE MURINE PI3K P110DELTA IN COMPLEX WITH A PAN INHIBITOR
204, p5cchF1, 0.7189, 3.01, 0.140, 149, 121, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
205, d5w5dF_, 0.7187, 3.19, 0.161, 153, 124, CRYSTAL STRUCTURE OF THE PRIMED SNARE-COMPLEXIN-SYNAPTOTAGMIN-1 C2B COMPLEX
206, p2wxoA1, 0.7187, 3.26, 0.161, 153, 124, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH AS5.
207, p2wxhA1, 0.7186, 2.86, 0.122, 171, 123, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH SW14.
208, p4y1sA_, 0.7185, 2.91, 0.161, 374, 118, STRUCTURAL BASIS FOR CA2+-MEDIATED INTERACTION OF THE PERFORIN C2 DOMAIN WITH LIPID MEMBRANES
209, p3w57A_, 0.7183, 3.20, 0.161, 153, 124, STRUCTURE OF A C2 DOMAIN
210, p6ftnA1, 0.7181, 2.89, 0.153, 376, 118, MPI3KD IN COMPLEX WITH AZ2 
211, d5h4zB_, 0.7181, 2.83, 0.230, 132, 113, CRYSTAL STRUCTURE OF S202G MUTANT OF HUMAN SYT-5 C2A DOMAIN
212, p5sx8A5, 0.7179, 2.79, 0.250, 148, 112, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 12 AND 15
213, p5cciF1, 0.7179, 2.91, 0.161, 370, 118, STRUCTURE OF THE MG2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
214, p2wxpA1, 0.7179, 2.90, 0.161, 371, 118, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH GDC-0941.
215, p3w57B_, 0.7177, 3.13, 0.164, 156, 122, STRUCTURE OF A C2 DOMAIN
216, d1e8wA2, 0.7175, 2.52, 0.227, 144, 110, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
217, p5kj8F1, 0.7174, 2.53, 0.255, 151, 110, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
218, d5h4zA_, 0.7174, 3.28, 0.161, 153, 124, CRYSTAL STRUCTURE OF S202G MUTANT OF HUMAN SYT-5 C2A DOMAIN
219, p2wxqA1, 0.7174, 1.47, 0.245, 106, 102, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH AS15.
220, p5ccgF1, 0.7172, 2.90, 0.153, 371, 118, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
221, p2wxmA1, 0.7172, 2.89, 0.153, 370, 118, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH DL06.
222, p5sxiA6, 0.7170, 2.11, 0.271, 125, 107, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 13
223, d5h4yA_, 0.7170, 2.15, 0.271, 126, 107, CRYSTAL STRUCTURE OF HUMAN SYNAPTOTAGMIN 5 C2A DOMAIN
224, p5lobA_, 0.7169, 2.80, 0.250, 151, 112, STRUCTURE OF THE CA2+-BOUND RABPHILIN3A C2B- SNAP25 COMPLEX (C2 SPACE GROUP)
225, p5kj7F1, 0.7166, 2.79, 0.259, 148, 112, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
226, p2wxjA1, 0.7166, 2.90, 0.161, 364, 118, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH INK654.
227, p3hhmA3, 0.7158, 2.21, 0.269, 128, 108, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA AND THE DRUG WORTMANNIN
228, p5i4uA5, 0.7157, 2.90, 0.169, 377, 118, THE CRYSTAL STRUCTURE OF PI3KDELTA WITH COMPOUND 34
229, p5ae8A2, 0.7156, 2.62, 0.255, 147, 110, CRYSTAL STRUCTURE OF MOUSE PI3 KINASE DELTA IN COMPLEX WITH GSK2269557
230, p5t7fA1, 0.7155, 2.59, 0.255, 147, 110, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-643624
231, p3hn8C2, 0.7152, 2.61, 0.255, 147, 110, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
232, p3hn8B2, 0.7152, 2.91, 0.161, 370, 118, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
233, p3hn8A2, 0.7151, 2.03, 0.271, 126, 107, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
234, d2b3rB1, 0.7150, 2.78, 0.250, 152, 112, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF CLASS II PHOSPHATIDYLINOSITIDE 3-KINASE C2
235, d5lo8A_, 0.7149, 2.92, 0.161, 370, 118, THE C2B DOMAIN OF RABPHILIN 3A IN COMPLEX WITH PI(45)P2
236, d5lowI_, 0.7145, 2.90, 0.161, 371, 118, STRUCTURE OF THE CA2+-BOUND RABPHILIN 3A C2B DOMAIN SNAP25 COMPLEX (P21 SPACE GROUP)
237, d4dnlA_, 0.7144, 2.08, 0.202, 122, 109, CRYSTAL STRUCTURE OF A C2 DOMAIN OF A PROTEIN KINASE C ALPHA (PRKCA) FROM HOMO SAPIENS AT 1.90 A RESOLUTION
238, d5lowB_, 0.7141, 2.25, 0.243, 111, 111, STRUCTURE OF THE CA2+-BOUND RABPHILIN 3A C2B DOMAIN SNAP25 COMPLEX (P21 SPACE GROUP)
239, p5sxeA5, 0.7140, 2.25, 0.243, 111, 111, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 19 AND 28
240, d2v4lA2, 0.7139, 2.95, 0.153, 375, 118, COMPLEX OF HUMAN PHOSPHOINOSITIDE 3-KINASE CATALYTIC SUBUNIT GAMMA (P110 GAMMA) WITH PIK-284
241, p5sxdA6, 0.7138, 2.18, 0.234, 128, 107, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 22
242, d2b3rA1, 0.7137, 3.19, 0.163, 152, 123, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF CLASS II PHOSPHATIDYLINOSITIDE 3-KINASE C2
243, p5t8iA1, 0.7131, 2.22, 0.271, 125, 107, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-9901
244, d5lowA_, 0.7131, 2.93, 0.161, 370, 118, STRUCTURE OF THE CA2+-BOUND RABPHILIN 3A C2B DOMAIN SNAP25 COMPLEX (P21 SPACE GROUP)
245, d3s2aA2, 0.7130, 2.27, 0.243, 111, 111, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH A QUINOLINE INHIBITOR
246, d3apfA2, 0.7130, 3.06, 0.143, 143, 119, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5039699
247, p5sxcA5, 0.7127, 2.36, 0.266, 127, 109, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 8
248, d5g55A2, 0.7126, 2.18, 0.234, 129, 107, 3-QUINOLINE CARBOXAMIDES INHIBITORS OF PI3K
249, d4wwpA2, 0.7125, 2.92, 0.161, 371, 118, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH PYRIDINYLQUINOLINE INHIBITOR N-{(1S)-1-[8-CHLORO-2-(2-METHYLPYRIDIN- 3-YL)QUINOLIN-3-YL]ETHYL}-9H-PURIN-6-AMINE
250, p3hizA3, 0.7125, 2.19, 0.269, 127, 108, CRYSTAL STRUCTURE OF P110ALPHA H1047R MUTANT IN COMPLEX WITH NISH2 OF P85ALPHA
251, p5dxtA2, 0.7118, 2.94, 0.161, 371, 118, P110ALPHA WITH GDC-0326
252, d1e7vA2, 0.7115, 3.28, 0.163, 151, 123, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
253, p4bfrB1, 0.7113, 2.30, 0.241, 126, 108, DISCOVERY AND OPTIMIZATION OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
254, p4a55A3, 0.7113, 2.24, 0.224, 138, 107, CRYSTAL STRUCTURE OF P110ALPHA IN COMPLEX WITH ISH2 OF P85ALPHA AND THE INHIBITOR PIK-108
255, d2cm6B_, 0.7112, 2.15, 0.269, 127, 108, CRYSTAL STRUCTURE OF THE C2B DOMAIN OF RABPHILIN3A
256, d4dk5A2, 0.7111, 2.94, 0.161, 371, 118, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL- TRIAZINE INHIBITOR
257, d4f1sA2, 0.7110, 3.41, 0.161, 153, 124, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH A PYRIDYL- TRIAZINE-SULFONAMIDE INHIBITOR
258, p5cchE1, 0.7109, 2.83, 0.155, 141, 116, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
259, p5vfeB_, 0.7107, 2.85, 0.155, 155, 116, SYNAPTOTAGMIN 1 C2A DOMAIN; LEAD-BOUND 
260, p2wxrA1, 0.7106, 2.98, 0.153, 371, 118, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA.
261, d5lowH_, 0.7105, 2.58, 0.209, 151, 110, STRUCTURE OF THE CA2+-BOUND RABPHILIN 3A C2B DOMAIN SNAP25 COMPLEX (P21 SPACE GROUP)
262, p2wxnA1, 0.7105, 2.58, 0.209, 151, 110, THE CRYSTAL STRUCTURE OF THE MURINE CLASS IA PI 3-KINASE P110DELTA IN COMPLEX WITH DL07.
263, p5cciE1, 0.7104, 2.58, 0.209, 151, 110, STRUCTURE OF THE MG2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
264, d5lo8B_, 0.7101, 2.07, 0.160, 122, 106, THE C2B DOMAIN OF RABPHILIN 3A IN COMPLEX WITH PI(45)P2
265, d5kaeA2, 0.7101, 2.32, 0.231, 140, 108, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH QUINOLINE- CONTAINING INHIBITOR 5G
266, p3l54A3, 0.7099, 2.51, 0.227, 145, 110, STRUCTURE OF PI3K GAMMA WITH INHIBITOR
267, d3qarA2, 0.7097, 3.08, 0.212, 133, 113, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 32
268, d3f04A1, 0.7096, 2.45, 0.229, 144, 109, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN I C2A DOMAIN
269, p5kj8E1, 0.7093, 3.22, 0.165, 151, 121, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
270, d3f01A1, 0.7091, 3.07, 0.153, 137, 118, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN I C2A DOMAIN WITH CU(II)
271, d1e8xA2, 0.7091, 3.26, 0.164, 151, 122, STRUCTURAL INSIGHTS INTO PHOSHOINOSITIDE 3-KINASE ENZYMATIC MECHANISM AND SIGNALLING
272, p5t7fB1, 0.7087, 2.11, 0.160, 122, 106, PI3KDELTA IN COMPLEX WITH THE INHIBITOR GS-643624
273, d4weeA1, 0.7087, 2.11, 0.160, 122, 106, HIGH-RESOLUTION STRUCTURE OF SYNAPTOTAGMIN 1 C2A
274, p4p42B1, 0.7087, 2.96, 0.162, 361, 117, EXTENDED-SYNAPTOTAGMIN 2 SMP - C2A - C2B DOMAINS
275, p5lobC_, 0.7086, 2.35, 0.222, 142, 108, STRUCTURE OF THE CA2+-BOUND RABPHILIN3A C2B- SNAP25 COMPLEX (C2 SPACE GROUP)
276, d3qaqA2, 0.7086, 2.96, 0.155, 140, 116, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH TRIAZINE-BENZIMIDAZOLE 2 1
277, d3csfA2, 0.7085, 3.18, 0.151, 138, 119, CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR DW2
278, p5sx9A6, 0.7084, 3.28, 0.172, 150, 122, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 14
279, p5t27A5, 0.7081, 3.20, 0.143, 140, 119, MPI3KD IN COMPLEX WITH 5D
280, d1qmmA2, 0.7081, 2.94, 0.155, 140, 116,  
281, p4xe0A1, 0.7078, 3.33, 0.161, 157, 124, IDELALISIB BOUND TO THE P110 SUBUNIT OF PI3K DELTA
282, d4fjyA2, 0.7076, 2.99, 0.154, 143, 117, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH QUINOLINE-INDOLINE INHIBITOR 24F
283, p5ccgK1, 0.7075, 3.33, 0.142, 140, 120, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
284, p5vfeA_, 0.7073, 3.38, 0.148, 401, 122, SYNAPTOTAGMIN 1 C2A DOMAIN; LEAD-BOUND 
285, p5t2iA1, 0.7072, 3.38, 0.148, 401, 122, MPI3KD IN COMPLEX WITH 7K
286, p5kj7E1, 0.7072, 3.24, 0.165, 150, 121, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
287, p5t2mA1, 0.7071, 2.37, 0.222, 148, 108, MPI3KD IN COMPLEX WITH 7M
288, p5kj7K1, 0.7069, 2.96, 0.155, 140, 116, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM XFEL DIFFRACTION
289, d3apcA2, 0.7068, 3.11, 0.145, 140, 117, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5132799
290, p5t2bA1, 0.7067, 2.29, 0.269, 128, 108, MPI3KD IN COMPLEX WITH 5E
291, d5lowJ_, 0.7066, 2.18, 0.274, 124, 106, STRUCTURE OF THE CA2+-BOUND RABPHILIN 3A C2B DOMAIN SNAP25 COMPLEX (P21 SPACE GROUP)
292, p5sxfA6, 0.7065, 3.01, 0.161, 370, 118, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 9
293, d4fjzA2, 0.7065, 2.46, 0.229, 140, 109, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH PYRROLO-PYRIDINE INHIBITOR 63
294, d3f05A1, 0.7063, 3.00, 0.161, 371, 118, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN I C2A DOMAIN WITH MN(II)
295, d2r83B2, 0.7063, 2.54, 0.266, 128, 109, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
296, d3f00A1, 0.7062, 2.46, 0.222, 142, 108, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN I C2A DOMAIN WITH CU(II)
297, p5sxjA5, 0.7059, 2.98, 0.147, 141, 116, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENT 29
298, d4wwnA2, 0.7058, 3.51, 0.165, 138, 121, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH (S)-N-(1-(7- FLUORO-2-(PYRIDIN-2-YL)QUINOLIN-3-YL)ETHYL)-9H-PURIN-6-AMINE AMG319 INHIBITOR
299, d4flhA2, 0.7058, 2.84, 0.148, 138, 115, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH AMG511
300, p5ccgE1, 0.7057, 2.33, 0.271, 126, 107, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM)
301, d4anuA2, 0.7056, 2.47, 0.266, 129, 109, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
302, p5ug6A_, 0.7055, 2.31, 0.271, 126, 107, PERFORIN C2 DOMAIN - T431D
303, d2r83A2, 0.7051, 3.10, 0.145, 136, 117, CRYSTAL STRUCTURE ANALYSIS OF HUMAN SYNAPTOTAGMIN 1 C2A-C2B
304, p5t2dA1, 0.7050, 2.98, 0.154, 367, 117, MPI3KD IN COMPLEX WITH 7J
305, d3tl5A2, 0.7046, 2.09, 0.274, 126, 106, DISCOVERY OF GDC-0980: A POTENT SELECTIVE AND ORALLY AVAILABLE CLASS I PHOSPHATIDYLINOSITOL 3-KINASE (PI3K)/MAMMALIAN TARGET OF RAPAMYCIN (MTOR) KINASE INHIBITOR FOR THE TREATMENT OF CANCER
306, d3eneA2, 0.7045, 1.72, 0.223, 108, 103, COMPLEX OF PI3K GAMMA WITH AN INHIBITOR
307, p5t2gA1, 0.7043, 2.33, 0.224, 138, 107, MPI3KD IN COMPLEX WITH 7I
308, p5ncyA1, 0.7041, 3.12, 0.154, 140, 117, MPI3KD IN COMPLEX WITH INH1
309, d3fdwA_, 0.7041, 3.09, 0.145, 135, 117, CRYSTAL STRUCTURE OF A C2 DOMAIN FROM HUMAN SYNAPTOTAGMIN- LIKE PROTEIN 4
310, p3w56A_, 0.7037, 3.22, 0.165, 149, 121, STRUCTURE OF A C2 DOMAIN
311, d3l16A2, 0.7037, 3.02, 0.171, 141, 117, DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT SELECTIVE AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3- KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER
312, p5nczA1, 0.7036, 3.11, 0.145, 136, 117, MPI3KD IN COMPLEX WITH INH1
313, d3fdwB_, 0.7036, 2.98, 0.171, 366, 117, CRYSTAL STRUCTURE OF A C2 DOMAIN FROM HUMAN SYNAPTOTAGMIN- LIKE PROTEIN 4
314, d4anxA2, 0.7035, 2.84, 0.157, 140, 115, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
315, p5kj8K1, 0.7030, 2.34, 0.269, 129, 108, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (LONG UNIT CELL FORM) - FROM SYNCHROTRON DIFFRACTION
316, d3rpbA_, 0.7029, 2.14, 0.274, 125, 106, THE C2B-DOMAIN OF RABPHILIN: STRUCTURAL VARIATIONS IN A JANUS-FACED DOMAIN
317, d4ps8A2, 0.7028, 2.97, 0.155, 368, 116, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH N-[6-(56-DIMETHOXYPYRIDIN-3- YL)-13-BENZOTHIAZOL-2-YL]ACETAMIDE
318, d4anwA2, 0.7028, 2.46, 0.266, 129, 109, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
319, d1e90A2, 0.7027, 2.95, 0.164, 368, 116, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
320, d1dqvA1, 0.7027, 2.34, 0.269, 129, 108, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN III C2A/C2B
321, d3apdA2, 0.7026, 3.09, 0.154, 136, 117, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH CH5108134
322, d4urkA2, 0.7025, 2.96, 0.164, 368, 116, PI3KG IN COMPLEX WITH AZD6482
323, d4ps3A2, 0.7024, 2.29, 0.226, 140, 106, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH 1-[6-(5-METHOXYPYRIDIN-3-YL)- 13-BENZOTHIAZOL-2-YL]-3-[2-(1-PROPYL-1H-IMIDAZOL-4-YL)ETHYL]UREA
324, d3nzsA2, 0.7022, 3.26, 0.165, 149, 121, STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE
325, d4lcvC_, 0.7020, 2.78, 0.167, 136, 114, CRYSTAL STRUCTURE OF DOC2B C2A DOMAIN
326, d4ps7A2, 0.7018, 2.17, 0.276, 124, 105, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH N-[6-(PYRIDIN-3-YL)-13- BENZOTHIAZOL-2-YL]ACETAMIDE
327, p5lobB_, 0.7017, 2.48, 0.269, 128, 108, STRUCTURE OF THE CA2+-BOUND RABPHILIN3A C2B- SNAP25 COMPLEX (C2 SPACE GROUP)
328, d4wwoA2, 0.7017, 2.11, 0.274, 126, 106, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH PHENYLQUINOLINE INHIBITOR N-{(1S)-1-[8-CHLORO-2-(3-FLUOROPHENYL)QUINOLIN-3-YL]ETHYL}- 9H-PURIN-6-AMINE
329, d3zvvA2, 0.7013, 3.29, 0.165, 151, 121, FRAGMENT BOUND TO PI3KINASE GAMMA
330, p6ewgA_, 0.7012, 2.97, 0.157, 139, 115, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) 
331, d4lt7A_, 0.7011, 3.10, 0.147, 139, 116, CRYSTAL STRUCTURE OF THE C2A DOMAIN OF RABPHILIN-3A IN COMPLEX WITH A CALCIUM
332, d3qk0A2, 0.7009, 2.48, 0.266, 129, 109, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH BENZOTHIAZOLE 82
333, d4ts6A_, 0.7007, 2.48, 0.266, 129, 109, CRYSTAL STRUCTURE OF THE RIM C2A DOMAIN FROM DROSOPHILA.
334, d3l13A2, 0.7007, 3.13, 0.154, 136, 117, CRYSTAL STRUCTURES OF PAN-PI3-KINASE AND DUAL PAN-PI3-KINASE/MTOR INHIBITORS
335, d5oq4A2, 0.7005, 2.28, 0.211, 123, 109, PQR309 - A POTENT BRAIN-PENETRANT ORALLY BIOAVAILABLE PAN-CLASS I PI3K/MTOR INHIBITOR AS CLINICAL CANDIDATE IN ONCOLOGY
336, d5edsA2, 0.6997, 2.50, 0.269, 128, 108, CRYSTAL STRUCTURE OF HUMAN PI3K-GAMMA IN COMPLEX WITH BENZIMIDAZOLE INHIBITOR 5
337, p6ewhA_, 0.6996, 2.98, 0.155, 368, 116, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) G307S MUTANT 
338, d4xz4A2, 0.6996, 3.21, 0.153, 137, 118, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH AN INHIBITOR
339, d2chxA2, 0.6995, 3.08, 0.154, 136, 117, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90
340, d3dbsA2, 0.6994, 2.99, 0.164, 368, 116, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH GDC0941
341, d4fulA2, 0.6991, 2.98, 0.155, 375, 116, PI3 KINASE GAMMA BOUND TO A PYRMIDINE INHIBITOR
342, p4ajwB1, 0.6990, 2.48, 0.213, 130, 108, DISCOVERY AND OPTIMIZATION OF NEW BENZIMIDAZOLE- AND BENZOXAZOLE- PYRIMIDONE SELECTIVE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
343, p6ewlA_, 0.6989, 2.48, 0.213, 130, 108, DANIO RERIO CEP120 FIRST C2 DOMAIN (C2A) 
344, p5dxhD3, 0.6988, 2.24, 0.250, 108, 108, P110ALPHA/P85ALPHA WITH COMPOUND 5
345, p4icwA_, 0.6988, 3.07, 0.147, 135, 116, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
346, d4ezkA2, 0.6988, 2.98, 0.164, 375, 116, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
347, d4xx5A2, 0.6987, 2.47, 0.213, 130, 108, STRUCTURE OF PI3K GAMMA IN COMPLEX WITH AN INHIBITOR
348, d4anvA2, 0.6987, 3.12, 0.154, 136, 117, COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS.
349, d1he8A2, 0.6987, 2.36, 0.269, 129, 108, RAS G12V - PI 3-KINASE GAMMA COMPLEX
350, p6dgtA1, 0.6986, 2.72, 0.225, 140, 111, SELECTIVE PI3K BETA INHIBITOR BOUND TO PI3K DELTA 
351, d4hleA2, 0.6985, 3.11, 0.145, 136, 117, COMPOUND 21 (1-ALKYL-SUBSTITUTED 124-TRIAZOLES)
352, d3tjpA2, 0.6985, 3.13, 0.154, 136, 117, CRYSTAL STRUCTURE OF PI3K GAMMA WITH N6-(34-DIMETHOXYPHENYL)-2- MORPHOLINO-[45 -BIPYRIMIDINE]-2 6-DIAMINE
353, d4j6iA2, 0.6984, 3.07, 0.147, 134, 116, DISCOVERY OF THIAZOLOBENZOXEPIN PI3-KINASE INHIBITORS THAT SPARE THE PI3-KINASE BETA ISOFORM
354, d3fbkA_, 0.6984, 2.26, 0.280, 130, 107, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE HUMAN REGULATOR OF G-PROTEIN SIGNALING 3 ISOFORM 6 (RGP3) NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR5550A
355, d2chdA_, 0.6984, 2.26, 0.280, 130, 107, CRYSTAL STRUCTURE OF THE C2A DOMAIN OF RABPHILIN-3A
356, d3ibeA2, 0.6980, 2.99, 0.148, 135, 115, CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR BOUND TO PI3 KINASE GAMMA
357, p4v0iB1, 0.6978, 3.06, 0.155, 136, 116, WATER NETWORK DETERMINES SELECTIVITY FOR A SERIES OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS OVER PI3K-DELTA
358, d3oawA2, 0.6978, 3.10, 0.145, 136, 117, 4-METHYLPTERIDINEONES AS ORALLY ACTIVE AND SELECTIVE PI3K/MTOR DUAL INHIBITORS
359, d2cm6A_, 0.6978, 3.19, 0.162, 138, 117, CRYSTAL STRUCTURE OF THE C2B DOMAIN OF RABPHILIN3A
360, d3fbkB_, 0.6975, 2.36, 0.231, 129, 108, CRYSTAL STRUCTURE OF THE C2 DOMAIN OF THE HUMAN REGULATOR OF G-PROTEIN SIGNALING 3 ISOFORM 6 (RGP3) NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR5550A
361, d6ankA1, 0.6974, 3.11, 0.154, 136, 117, SYNAPTOTAGMIN-7 C2A- AND C2B-DOMAINS
362, d1e8yA2, 0.6973, 2.24, 0.226, 139, 106, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
363, p4fa6A3, 0.6970, 2.97, 0.149, 139, 114, DESIGN AND SYNTHESIS OF A NOVEL PYRROLIDINYL PYRIDO PYRIMIDINONE DERIVATIVE AS A POTENT INHIBITOR OF PI3KA AND MTOR
364, d4np9A_, 0.6969, 3.11, 0.155, 135, 116, STRUCTURE OF RABPHILIN C2A DOMAIN BOUND TO IP3
365, p5ubrA3, 0.6967, 3.06, 0.100, 181, 120, CRYSTAL STRUCTURE OF PI3K ALPHA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1- YL)PHENYL)PYRROLO[21-F][124] TRIAZIN-4-AMINE DERIVIATINE
366, d3l17A2, 0.6967, 2.63, 0.220, 128, 109, DISCOVERY OF (THIENOPYRIMIDIN-2-YL)AMINOPYRIMIDINES AS POTENT SELECTIVE AND ORALLY AVAILABLE PAN-PI3-KINASE AND DUAL PAN-PI3- KINASE/MTOR INHIBITORS FOR THE TREATMENT OF CANCER
367, d1e8zA2, 0.6965, 2.93, 0.149, 134, 114, STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY WORTMANNIN LY294002 QUERCETIN MYRICETIN AND STAUROSPORINE
368, d1w15A_, 0.6953, 2.43, 0.198, 126, 106, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE PRESENCE OF CALCIUM
369, d4lcvD_, 0.6950, 3.10, 0.147, 135, 116, CRYSTAL STRUCTURE OF DOC2B C2A DOMAIN
370, d4ns0A_, 0.6948, 3.04, 0.157, 134, 115, THE C2A DOMAIN OF RABPHILIN 3A IN COMPLEX WITH PI(45)P2
371, d4fhjA2, 0.6948, 2.99, 0.149, 138, 114, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDINE 2
372, d3ps6A2, 0.6948, 3.05, 0.100, 181, 120, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
373, d3przA2, 0.6948, 3.10, 0.154, 136, 117, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
374, p4icxB_, 0.6947, 3.09, 0.155, 136, 116, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
375, d4fhkA2, 0.6946, 3.10, 0.147, 135, 116, CRYSTAL STRUCTURE OF PI3K-GAMMA IN COMPLEX WITH IMIDAZOPYRIDAZINE 19E
376, d6anjA1, 0.6943, 2.90, 0.150, 132, 113, SYNAPTOTAGMIN-7 C2A DOMAIN
377, d3lj3A2, 0.6943, 2.90, 0.149, 346, 114, PI3-KINASE-GAMMA WITH A PYRROLOPYRIDINE-BENZOFURAN INHIBITOR
378, d6ankB1, 0.6941, 3.15, 0.179, 136, 117, SYNAPTOTAGMIN-7 C2A- AND C2B-DOMAINS
379, p6fljA_, 0.6939, 2.87, 0.168, 136, 113, CRYSTAL STRUCTURE OF CEP120 C2A_K76A MUTANT
380, d4lcvB1, 0.6938, 2.93, 0.172, 130, 116, CRYSTAL STRUCTURE OF DOC2B C2A DOMAIN
381, d4ezlA2, 0.6935, 3.12, 0.155, 135, 116, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
382, d4ezjA2, 0.6931, 3.12, 0.145, 136, 117, POTENT AND SELECTIVE INHIBITORS OF PI3K-DELTA: OBTAINING ISOFORM SELECTIVITY FROM THE AFFINITY POCKET AND TRYPTOPHAN SHELF
383, d4gb9A2, 0.6926, 3.11, 0.147, 141, 116, POTENT AND HIGHLY SELECTIVE BENZIMIDAZOLE INHIBITORS OF PI3K-DELTA
384, p5cciF2, 0.6925, 2.89, 0.158, 138, 114, STRUCTURE OF THE MG2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
385, p3zimA3, 0.6925, 3.02, 0.157, 350, 115, DISCOVERY OF A POTENT AND ISOFORM-SELECTIVE TARGETED COVALENT INHIBITOR OF THE LIPID KINASE PI3KALPHA
386, p3hn8C1, 0.6924, 3.25, 0.162, 138, 117, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
387, p3hn8B1, 0.6923, 3.09, 0.148, 136, 115, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
388, p3hn8A1, 0.6923, 3.11, 0.155, 135, 116, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN
389, d3nzuA2, 0.6922, 2.81, 0.209, 137, 110, STRUCTURE-BASED OPTIMIZATION OF PYRAZOLO -PYRIMIDINE AND -PYRIDINE INHIBITORS OF PI3-KINASE
390, d6audA2, 0.6920, 2.81, 0.209, 137, 110, PI3K-GAMMA K802T IN COMPLEX WITH CPD 8 10-((1-(TERT-BUTYL)PIPERIDIN-4- YL)SULFINYL)-2-(1-ISOPROPYL-1H-124-TRIAZOL-5-YL)-56- DIHYDROBENZO[F]IMIDAZO[12-D][14]OXAZEPINE
391, p5kc2C1, 0.6916, 2.66, 0.220, 128, 109, NEGATIVE STAIN STRUCTURE OF VPS15/VPS34 COMPLEX
392, p5dfzC1, 0.6916, 3.08, 0.148, 134, 115, STRUCTURE OF VPS34 COMPLEX II FROM S. CEREVISIAE.
393, p6c1sA3, 0.6914, 2.89, 0.149, 351, 114, PHOSPHOINOSITIDE 3-KINASE GAMMA BOUND TO AN PYRROLOPYRIDINONE INHIBITOR 
394, d3preA2, 0.6914, 2.89, 0.149, 351, 114, QUINAZOLINES WITH INTRA-MOLECULAR HYDROGEN BONDING SCAFFOLD (IMHBS) AS PI3K/MTOR DUAL INHIBITORS.
395, p4fadA3, 0.6912, 3.14, 0.148, 138, 115, DESIGN AND SYNTHESIS OF A NOVEL PYRROLIDINYL PYRIDO PYRIMIDINONE DERIVATIVE AS A POTENT INHIBITOR OF PI3KA AND MTOR
396, p3r7rA3, 0.6912, 2.12, 0.231, 149, 104, STRUCTURE-BASED DESIGN OF THIENOBENZOXEPIN INHIBITORS OF PI3-KINASE
397, d2k4aA_, 0.6910, 2.12, 0.231, 149, 104, FGF-1-C2A BINARY COMPLEX STRUCTURE: A KEY COMPONENT IN THE FIBROBLAST GROWTHFACTOR NON-CLASSICAL PATHWAY
398, d2chzA2, 0.6908, 2.88, 0.200, 137, 110, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-93
399, d2chwA2, 0.6908, 2.43, 0.283, 125, 106, A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110 ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-39
400, p4icxA_, 0.6907, 3.20, 0.147, 135, 116, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
401, d2k3hA_, 0.6907, 3.01, 0.158, 133, 114, STRUCTURAL DETERMINANTS FOR CA2+ AND PIP2 BINDING BY THE C2A DOMAIN OF RABPHILIN-3A
402, p6flkA_, 0.6906, 2.54, 0.222, 128, 108, CRYSTAL STRUCTURE OF CEP120 C2C DOMAIN
403, d2a5uA2, 0.6904, 2.79, 0.150, 136, 113, CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS605240
404, d1dqvA2, 0.6904, 3.11, 0.155, 135, 116, CRYSTAL STRUCTURE OF SYNAPTOTAGMIN III C2A/C2B
405, p4icxC_, 0.6902, 3.21, 0.147, 135, 116, N-TERMINAL C2 DOMAIN OF HUMAN CEP120
406, p6flkB_, 0.6900, 2.28, 0.214, 132, 103, CRYSTAL STRUCTURE OF CEP120 C2C DOMAIN
407, d2cm5A_, 0.6900, 2.28, 0.214, 132, 103, CRYSTAL STRUCTURE OF THE C2B DOMAIN OF RABPHILIN
408, p3t8mA3, 0.6897, 2.49, 0.224, 126, 107, RATIONAL DESIGN OF PI3K-ALPHA INHIBITORS THAT EXHIBIT SELECTIVITY OVER THE PI3K-BETA ISOFORM
409, d3ml9A2, 0.6894, 2.56, 0.222, 128, 108, DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN
410, p6ewiB_, 0.6891, 3.09, 0.149, 133, 114, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) A200P + G307S MUTANT 
411, p6ewiA_, 0.6889, 3.15, 0.148, 138, 115, OREOCHROMIS NILOTICUS CEP120 SECOND C2 DOMAIN (C2B) A200P + G307S MUTANT 
412, p5sw8A5, 0.6887, 3.16, 0.148, 139, 115, CRYSTAL STRUCTURE OF PI3KALPHA IN COMPLEX WITH FRAGMENTS 7 AND 11
413, d2ki6A_, 0.6887, 2.93, 0.165, 129, 115, THE FGF1-S100A13-C2A HETERO-HEXAMERIC COMPLEX STRUCTURE: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR FGF1 SECRETION
414, p5m6uA4, 0.6886, 3.08, 0.149, 133, 114, HUMAN PI3KDELTA IN COMPLEX WITH LASW1579
415, d5g2nA4, 0.6883, 2.71, 0.275, 129, 109, X-RAY STRUCTURE OF PI3KINASE GAMMA IN COMPLEX WITH COPANLISIB
416, d3l08A2, 0.6869, 2.71, 0.275, 129, 109, STRUCTURE OF PI3K GAMMA WITH A POTENT INHIBITOR: GSK2126458
417, p5i6uA1, 0.6867, 3.12, 0.149, 133, 114, THE CRYSTAL STRUCTURE OF PI3KDELTA WITH COMPOUND 32
418, d4kz0A2, 0.6867, 2.43, 0.283, 125, 106, STRUCTURE OF PI3K GAMMA WITH IMIDAZOPYRIDINE INHIBITORS
419, p3cstA3, 0.6860, 2.93, 0.174, 127, 115, CRYSTAL STRUCTURE OF PI3K P110GAMMA CATALYTICAL DOMAIN IN COMPLEX WITH ORGANORUTHENIUM INHIBITOR E5E2
420, d2ki6F_, 0.6856, 2.66, 0.227, 130, 110, THE FGF1-S100A13-C2A HETERO-HEXAMERIC COMPLEX STRUCTURE: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR FGF1 SECRETION
421, p5w4sA_, 0.6848, 2.66, 0.227, 130, 110, SOLUTION STRUCTURE OF C2 DOMAIN FROM PROTEIN KINASE C ALPHA IN TERNARY COMPLEX WITH CALCIUM AND V5-PHM PEPTIDE 
422, p4xbmB1, 0.6845, 3.21, 0.155, 135, 116, X-RAY CRYSTAL STRUCTURE OF NOTCH LIGAND DELTA-LIKE 1
423, d3mjwA2, 0.6843, 3.22, 0.155, 135, 116, PI3 KINASE GAMMA WITH A BENZOFURANONE INHIBITOR
424, d3dpdA2, 0.6842, 3.25, 0.155, 135, 116, ACHIEVING MULTI-ISOFORM PI3K INHIBITION IN A SERIES OF SUBSTITUTED 34-DIHYDRO-2H-BENZO[14]OXAZINES
425, p4g11A3, 0.6831, 2.70, 0.264, 143, 106, X-RAY STRUCTURE OF PI3K-GAMMA BOUND TO A 4-(MORPHOLIN-4-YL)- (6-OXO-1 6-DIHYDROPYRIMIDIN-2-YL)AMIDE INHIBITOR
426, d1v27A1, 0.6831, 2.83, 0.152, 135, 112, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN OF RIM2
427, d4lcvA_, 0.6821, 2.41, 0.264, 128, 106, CRYSTAL STRUCTURE OF DOC2B C2A DOMAIN
428, p4cc0A1, 0.6821, 2.42, 0.264, 128, 106, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
429, d2nceA_, 0.6812, 2.42, 0.264, 128, 106, SOLUTION STRUCTURE OF CA2+-BOUND C2 DOMAIN FROM PROTEIN KINASE C ALPHA IN THE FORM OF COMPLEX WITH V5-PHM PEPTIDE
430, d2k8mA1, 0.6812, 3.14, 0.148, 133, 115, S100A13-C2A BINARY COMPLEX STRUCTURE
431, p6gq7A3, 0.6809, 3.16, 0.157, 135, 115, PI3KG IN COMPLEX WITH INH 
432, d2k8mD1, 0.6807, 3.44, 0.157, 221, 127, S100A13-C2A BINARY COMPLEX STRUCTURE
433, p2q3xA_, 0.6806, 3.44, 0.157, 221, 127, THE RIM1ALPHA C2B DOMAIN
434, p5dfzA1, 0.6801, 3.44, 0.157, 221, 127, STRUCTURE OF VPS34 COMPLEX II FROM S. CEREVISIAE.
435, p2rd0A6, 0.6796, 2.84, 0.153, 131, 111, STRUCTURE OF A HUMAN P110ALPHA/P85ALPHA COMPLEX
436, p3r7qA3, 0.6794, 3.08, 0.149, 136, 114, STRUCTURE-BASED DESIGN OF THIENOBENZOXEPIN INHIBITORS OF PI3- KINASE
437, p6ez6A2, 0.6793, 3.36, 0.147, 136, 116, PI3 KINASE DELTA IN COMPLEX WITH METHYL 5-(4-(5-((4- ISOPROPYLPIPERAZIN-1-YL)METHYL)OXAZOL-2-YL)-1H-INDAZOL-6-YL)-2- METHOXYNICOTINATE
438, p5ae9A2, 0.6791, 2.89, 0.161, 131, 112, CRYSTAL STRUCTURE OF MOUSE PI3 KINASE DELTA IN COMPLEX WITH GSK2292767
439, p5mvxA1, 0.6788, 2.57, 0.266, 128, 109, HUMAN DLL4 C2-EGF3
440, d5jhaA4, 0.6767, 3.24, 0.155, 135, 116, STRUCTURE OF PHOSPHOINOSITIDE 3-KINASE GAMMA (PI3K) BOUND TO THE POTENT INHIBITOR PIKIN2
441, d2k45A_, 0.6763, 3.20, 0.155, 135, 116, C2A DOMAIN OF SYNAPTOTOTAGMIN I SOLUTION STRUCTURE IN THE FGF-1-C2A BINARY COMPLEX: KEY COMPONENT IN THE FIBROBLAST GROWTHFACTOR NON-CLASSICAL PATHWAY
442, d4hvbA2, 0.6760, 3.04, 0.164, 132, 116, CATALYTIC UNIT OF PI3KG IN COMPLEX WITH PI3K/MTOR DUAL INHIBITOR PF- 04979064
443, p4cc0B_, 0.6760, 3.04, 0.164, 132, 116, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
444, p4xoiD_, 0.6756, 2.63, 0.227, 127, 110, STRUCTURE OF HSANILLIN BOUND WITH RHOA(Q63L) AT 2.1 ANGSTROMS RESOLUTION
445, p4kzcA3, 0.6750, 2.68, 0.112, 154, 116, STRUCTURE OF PI3K GAMMA WITH IMIDAZOPYRIDINE INHIBITORS
446, p4xlwH_, 0.6749, 2.68, 0.112, 154, 116, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
447, p4xlwD1, 0.6746, 3.29, 0.147, 135, 116, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
448, d3ml8A2, 0.6745, 2.50, 0.239, 145, 109, DISCOVERY OF THE HIGHLY POTENT PI3K/MTOR DUAL INHIBITOR PF-04691502 THROUGH STRUCTURE BASED DRUG DESIGN
449, p4xlwF_, 0.6741, 2.99, 0.148, 130, 115, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
450, p6fjcB_, 0.6738, 2.72, 0.112, 154, 116, HUMAN KIBRA C2 DOMAIN MUTANT C771A IN COMPLEX WITH PHOSPHATIDYLINOSITOL 3;4;5-TRISPHOSPHATE 
451, p6fb4B_, 0.6738, 2.13, 0.233, 141, 103, HUMAN KIBRA C2 DOMAIN MUTANT C771A 
452, p4xlwB1, 0.6737, 2.90, 0.161, 131, 112, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF2)
453, p2q3xB_, 0.6724, 3.05, 0.150, 133, 113, THE RIM1ALPHA C2B DOMAIN
454, p4xl1E_, 0.6723, 3.22, 0.099, 182, 121, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF1)
455, d5t23A4, 0.6722, 3.23, 0.099, 174, 121, PI3KG IN COMPLEX WITH 5D
456, p4aofA3, 0.6720, 3.28, 0.144, 147, 118, SELECTIVE SMALL MOLECULE INHIBITOR DISCOVERED BY CHEMOPROTEOMIC ASSAY PLATFORM REVEALS REGULATION OF TH17 CELL DIFFERENTIATION BY PI3KGAMMA
457, d2bwqA_, 0.6716, 2.56, 0.266, 128, 109, CRYSTAL STRUCTURE OF THE RIM2 C2A-DOMAIN AT 1.4 ANGSTROM RESOLUTION
458, p4cc1A1, 0.6715, 2.55, 0.167, 134, 108, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
459, d2a4zA2, 0.6707, 3.08, 0.150, 132, 113, CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS604850
460, p6fjcA_, 0.6696, 3.08, 0.152, 136, 112, HUMAN KIBRA C2 DOMAIN MUTANT C771A IN COMPLEX WITH PHOSPHATIDYLINOSITOL 3;4;5-TRISPHOSPHATE 
461, p6fb4A_, 0.6695, 3.07, 0.165, 368, 115, HUMAN KIBRA C2 DOMAIN MUTANT C771A 
462, p6fjdA_, 0.6694, 3.09, 0.161, 129, 112, HUMAN KIBRA C2 DOMAIN MUTANT C771A IN COMPLEX WITH PHOSPHATIDYLINOSITOL 4;5-BISPHOSPHATE 
463, p3p2bA3, 0.6694, 3.01, 0.152, 131, 112, CRYSTAL STRUCTURE OF PI3K GAMMA WITH 3-(2-MORPHOLINO-6-(PYRIDIN-3- YLAMINO)PYRIMIDIN-4-YL)PHENOL
464, p3n0aA2, 0.6690, 2.58, 0.266, 128, 109, CRYSTAL STRUCTURE OF AUXILIN (40-400)
465, p3sd5A3, 0.6680, 3.11, 0.211, 139, 114, CRYSTAL STRUCTURE OF PI3K GAMMA WITH 5-(24-DIMORPHOLINOPYRIMIDIN-6- YL)-4-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE
466, p4xl1B_, 0.6676, 3.25, 0.118, 157, 119, COMPLEX OF NOTCH1 (EGF11-13) BOUND TO DELTA-LIKE 4 (N-EGF1)
467, p6fd0A_, 0.6675, 2.94, 0.153, 130, 111, HUMAN KIBRA C2 DOMAIN MUTANT M734I S735A 
468, p5mwfC1, 0.6667, 2.97, 0.143, 131, 112, HUMAN JAGGED2 C2-EGF2
469, p5o83A1, 0.6653, 3.00, 0.143, 131, 112, DISCOVERY OF CDZ173 (LENIOLISIB) REPRESENTING A STRUCTURALLY NOVEL CLASS OF PI3K DELTA-SELECTIVE INHIBITORS
470, d2d8kA1, 0.6650, 2.91, 0.167, 128, 108, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN OF SYNAPTOTAGMIN VII
471, p4cc1B1, 0.6649, 2.91, 0.167, 128, 108, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
472, d2dmgA1, 0.6647, 2.48, 0.231, 123, 104, SOLUTION STRUCTURE OF THE THIRD C2 DOMAIN OF KIAA1228 PROTEIN
473, d5jhbA4, 0.6638, 3.22, 0.126, 168, 119, STRUCTURE OF PHOSPHOINOSITIDE 3-KINASE GAMMA (PI3K) BOUND TO THE POTENT INHIBITOR PIKIN3
474, p5cchF2, 0.6631, 3.08, 0.214, 139, 112, STRUCTURE OF THE CA2+-BOUND SYNAPTOTAGMIN-1 SNARE COMPLEX (SHORT UNIT CELL FORM)
475, p5mwfE1, 0.6626, 2.49, 0.269, 126, 108, HUMAN JAGGED2 C2-EGF2
476, p5mw5A_, 0.6626, 3.14, 0.152, 136, 112, HUMAN JAGGED2 C2-EGF2
477, p5mwfB1, 0.6618, 2.50, 0.269, 126, 108, HUMAN JAGGED2 C2-EGF2
478, p5mwfA_, 0.6604, 2.83, 0.159, 137, 107, HUMAN JAGGED2 C2-EGF2
479, d2yrbA1, 0.6600, 2.55, 0.101, 119, 109, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN FROM HUMAN KIAA1005 PROTEIN
480, d1rh8A_, 0.6598, 2.55, 0.101, 119, 109, THREE-DIMENSIONAL STRUCTURE OF THE CALCIUM-FREE PICCOLO C2A- DOMAIN
481, p6fd0B_, 0.6570, 3.38, 0.160, 149, 119, HUMAN KIBRA C2 DOMAIN MUTANT M734I S735A 
482, p6fjdB_, 0.6565, 2.90, 0.155, 129, 110, HUMAN KIBRA C2 DOMAIN MUTANT C771A IN COMPLEX WITH PHOSPHATIDYLINOSITOL 4;5-BISPHOSPHATE 
483, p2z0uA_, 0.6557, 2.59, 0.178, 127, 107, CRYSTAL STRUCTURE OF C2 DOMAIN OF KIBRA PROTEIN
484, p5okmB2, 0.6554, 2.61, 0.168, 127, 107, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
485, p2z0uB_, 0.6543, 3.31, 0.083, 161, 120, CRYSTAL STRUCTURE OF C2 DOMAIN OF KIBRA PROTEIN
486, p5mwfD_, 0.6538, 3.05, 0.153, 130, 111, HUMAN JAGGED2 C2-EGF2
487, p5okmH2, 0.6510, 2.56, 0.269, 128, 108, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
488, p5okmF2, 0.6507, 3.04, 0.153, 130, 111, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
489, p4xbmA1, 0.6506, 3.28, 0.126, 168, 119, X-RAY CRYSTAL STRUCTURE OF NOTCH LIGAND DELTA-LIKE 1
490, p5oknE2, 0.6505, 3.28, 0.113, 208, 115, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
491, p5okmD2, 0.6504, 2.82, 0.157, 126, 108, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
492, p5okmE2, 0.6501, 3.37, 0.108, 159, 120, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
493, p5oknH2, 0.6499, 3.33, 0.108, 148, 120, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
494, p5mwfF_, 0.6496, 3.04, 0.153, 131, 111, HUMAN JAGGED2 C2-EGF2
495, p5oknF2, 0.6493, 3.38, 0.108, 159, 120, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
496, p5oknD2, 0.6489, 2.42, 0.162, 129, 105, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
497, p5okmG2, 0.6472, 2.47, 0.160, 129, 106, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
498, p5okoA2, 0.6471, 3.38, 0.108, 148, 120, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 DOUBLE MUTANT F593D/L597D
499, p5uk5B1, 0.6461, 2.63, 0.163, 140, 104, COMPLEX OF NOTCH1(EGF8-12) BOUND TO JAGGED1(N-EGF3)
500, p4cbzB_, 0.6460, 2.63, 0.163, 140, 104, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
501, d1w16A_, 0.6448, 3.38, 0.108, 161, 120, RAT SYNAPTOTAGMIN 4 C2B DOMAIN IN THE ABSENCE OF CALCIUM
502, p5oknA2, 0.6446, 3.38, 0.108, 161, 120, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
503, p5okmA2, 0.6428, 2.97, 0.155, 135, 110, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
504, d5bzzD2, 0.6420, 2.96, 0.155, 129, 110, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
505, d5bugA2, 0.6414, 2.52, 0.186, 122, 102, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
506, d2enpA1, 0.6414, 3.42, 0.098, 168, 122, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN FROM HUMAN B/K PROTEIN
507, p5oknB2, 0.6409, 3.12, 0.153, 129, 111, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
508, p5okmC2, 0.6402, 2.44, 0.162, 130, 105, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2
509, d5bzzA2, 0.6401, 2.51, 0.160, 129, 106, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
510, d2lhaA_, 0.6399, 2.51, 0.160, 129, 106, SOLUTION STRUCTURE OF C2B WITH IP6
511, d5bugC2, 0.6396, 2.78, 0.160, 124, 106, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
512, p5okoB2, 0.6389, 3.19, 0.144, 149, 118, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 DOUBLE MUTANT F593D/L597D
513, p4xohC1, 0.6386, 3.19, 0.144, 149, 118, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
514, d5bzxA2, 0.6385, 2.83, 0.160, 124, 106, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
515, d1ugkA1, 0.6379, 3.52, 0.117, 158, 120, SOLUTION STRUCTURE OF THE FIRST C2 DOMAIN OF SYNAPTOTAGMIN IV FROM HUMAN FETAL BRAIN (KIAA1342)
516, d4mjjA_, 0.6374, 2.62, 0.159, 129, 107, CRYSTAL STRUCTURE OF THE C2A DOMAIN OF DOC2A
517, d5bugD2, 0.6372, 3.33, 0.100, 162, 120, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
518, d5bzxD2, 0.6363, 3.11, 0.171, 347, 111, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
519, p5okpA2, 0.6358, 2.60, 0.299, 128, 107, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 DOUBLE MUTANT F593D/L597D
520, d5bugB2, 0.6358, 3.47, 0.098, 168, 122, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN OXIDIZED BY H2O2
521, d1bdyA_, 0.6356, 2.88, 0.196, 129, 107, C2 DOMAIN FROM PROTEIN KINASE C DELTA
522, d5bzzC2, 0.6355, 2.88, 0.196, 129, 107, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
523, d1bdyB_, 0.6355, 3.06, 0.156, 128, 109, C2 DOMAIN FROM PROTEIN KINASE C DELTA
524, d5bzzB2, 0.6354, 2.73, 0.265, 140, 102, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN IN ITS REDUCED STATE
525, p4xohB1, 0.6353, 3.37, 0.100, 160, 120, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
526, p5mw7A_, 0.6352, 3.37, 0.100, 159, 120, HUMAN JAGGED2 C2-EGF3
527, d5bzxC2, 0.6348, 3.40, 0.108, 175, 120, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
528, p4cbzA1, 0.6340, 3.37, 0.101, 177, 119, NOTCH LIGAND JAGGED-1 CONTAINS AN N-TERMINAL C2 DOMAIN
529, d5bzxB2, 0.6329, 3.37, 0.101, 177, 119, CRYSTAL STRUCTURE OF HUMAN PHOSPHATASE PTEN TREATED WITH A BISPEROXOVANADIUM COMPLEX
530, p2y3aA2, 0.6319, 3.48, 0.075, 143, 120, CRYSTAL STRUCTURE OF P110BETA IN COMPLEX WITH ICSH2 OF P85BETA AND THE DRUG GDC-0941
531, d1d5rA1, 0.6301, 3.48, 0.075, 143, 120, CRYSTAL STRUCTURE OF THE PTEN TUMOR SUPPRESSOR
532, d1yrkA1, 0.6282, 2.76, 0.222, 142, 108, THE C2 DOMAIN OF PKC<DELTA> IS A NEW PHOSPHO-TYROSINE BINDING DOMAIN
533, p4bfrA1, 0.6274, 2.76, 0.222, 142, 108, DISCOVERY AND OPTIMIZATION OF PYRIMIDONE INDOLINE AMIDE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
534, p4xohA1, 0.6272, 2.43, 0.163, 128, 104, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
535, p5oknC2, 0.6244, 2.47, 0.157, 126, 102, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
536, p3d34B_, 0.6243, 2.89, 0.159, 127, 107, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
537, d1wfmA1, 0.6242, 2.89, 0.159, 127, 107, THE FIRST C2 DOMAIN OF HUMAN SYNAPTOTAGMIN XIII
538, p3d34A_, 0.6224, 3.01, 0.070, 130, 115, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
539, d5w5cF1, 0.6212, 2.69, 0.162, 127, 105, CRYSTAL STRUCTURE OF THE PRIMED SNARE-COMPLEXIN-SYNAPTOTAGMIN-1 C2AB COMPLEX
540, p3q13A_, 0.6152, 3.46, 0.100, 168, 120, THE STRUCTURE OF THE CA2+-BINDING GLYCOSYLATED F-SPONDIN DOMAIN OF F- SPONDIN A C2-DOMAIN VARIANT FROM EXTRACELLULAR MATRIX
541, p5is5A1, 0.6135, 3.00, 0.070, 129, 114, DISCOVERY AND PHARMACOLOGICAL CHARACTERIZATION OF NOVEL QUINAZOLINE- BASED PI3K DELTA-SELECTIVE INHIBITORS
542, p4xoiB_, 0.6058, 3.01, 0.070, 129, 114, STRUCTURE OF HSANILLIN BOUND WITH RHOA(Q63L) AT 2.1 ANGSTROMS RESOLUTION
543, p4xh3A2, 0.6032, 3.56, 0.092, 153, 119, MECHANISTIC INSIGHTS INTO ANCHORAGE OF THE CONTRACTILE RING FROM YEAST TO HUMANS
544, p5waiF2, 0.5874, 3.04, 0.070, 128, 115, CRYSTAL STRUCTURE OF A SUZ12-RBBP4-JARID2-AEBP2 HETEROTETRAMERIC COMPLEX
545, p3v0dB2, 0.5855, 3.05, 0.070, 130, 115, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S)
546, p3v0dA2, 0.5844, 3.00, 0.070, 127, 114, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S)
547, p3v0hB2, 0.5835, 3.02, 0.070, 129, 114, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) COMPLEXED WITH D-MYO- INOSITOL-145-TRIPHOSPHATE
548, p3v0gB1, 0.5831, 3.45, 0.100, 156, 120, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
549, p3v0gD2, 0.5824, 3.01, 0.070, 127, 114, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
550, p3v0gA2, 0.5823, 3.06, 0.070, 129, 115, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
551, p3v0jA2, 0.5820, 3.05, 0.070, 129, 114, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) DELETION OF 401-405
552, p3v0hA2, 0.5811, 3.17, 0.060, 134, 116, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) COMPLEXED WITH D-MYO- INOSITOL-145-TRIPHOSPHATE
553, p3v0fA2, 0.5803, 3.17, 0.060, 134, 116, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM II
554, p3v0eA2, 0.5786, 3.55, 0.100, 167, 120, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 256-576(C363S)
555, p3v0jB2, 0.5780, 3.40, 0.102, 153, 118, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) DELETION OF 401-405
556, p3v0gC2, 0.5776, 2.35, 0.219, 125, 96, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
557, p3v0iA2, 0.5754, 3.09, 0.070, 130, 114, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 256-576 E411F
558, p3aweB2, 0.5728, 3.05, 0.071, 129, 113, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (248-576)
559, p3aweC2, 0.5722, 3.20, 0.094, 140, 117, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (248-576)
560, p3v0fB2, 0.5719, 3.19, 0.094, 140, 117, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM II
561, p3aweA2, 0.5711, 3.19, 0.094, 140, 117, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (248-576)
562, p3awgB2, 0.5707, 2.85, 0.224, 134, 107, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP G356A MUTANT (248-576)
563, p3awfB2, 0.5701, 2.85, 0.224, 134, 107, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (236-576)
564, p3awgC2, 0.5695, 3.07, 0.061, 130, 114, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP G356A MUTANT (248-576)
565, p3awgA2, 0.5675, 3.17, 0.060, 132, 116, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP G356A MUTANT (248-576)
566, p3awfA2, 0.5667, 3.22, 0.094, 140, 117, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (236-576)
567, p3awfC2, 0.5666, 3.09, 0.257, 151, 109, CRYSTAL STRUCTURE OF PTEN-LIKE DOMAIN OF CI-VSP (236-576)
568, d5k59A_, 0.5665, 3.22, 0.094, 140, 117, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
569, p5waiB2, 0.5628, 3.01, 0.071, 128, 112, CRYSTAL STRUCTURE OF A SUZ12-RBBP4-JARID2-AEBP2 HETEROTETRAMERIC COMPLEX
570, p5iz5B3, 0.5622, 2.99, 0.200, 167, 110, HUMAN GIVD CYTOSOLIC PHOSPHOLIPASE A2
571, d4tw1G_, 0.5552, 2.99, 0.200, 167, 110, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
572, d4tw1E_, 0.5539, 3.21, 0.094, 140, 117, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
573, d4p1yF1, 0.5491, 2.43, 0.202, 125, 104, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
574, d4p1yC_, 0.5486, 2.43, 0.202, 125, 104, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
575, d4p1yH1, 0.5485, 2.39, 0.250, 116, 96, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
576, d4tw1O_, 0.5483, 3.23, 0.094, 140, 117, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
577, d4p1xC_, 0.5481, 3.19, 0.094, 140, 117, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
578, d4p1yA_, 0.5480, 2.84, 0.055, 124, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
579, d4p1yB1, 0.5478, 3.23, 0.094, 140, 117, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
580, d4p1yG_, 0.5476, 2.62, 0.119, 123, 101, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
581, d4p1yD1, 0.5476, 3.27, 0.094, 140, 117, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
582, d4p1xE_, 0.5474, 2.91, 0.115, 123, 104, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
583, d1pvlA_, 0.5470, 3.25, 0.094, 140, 117, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN F COMPONENT FROM STAPHYLOCOCCUS AUREUS
584, d5k59C_, 0.5465, 3.20, 0.200, 141, 110, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
585, d4tw1H_, 0.5455, 3.65, 0.115, 168, 122, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
586, d5k59D_, 0.5454, 3.25, 0.094, 140, 117, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
587, p5oknG2, 0.5453, 3.59, 0.133, 153, 120, CRYSTAL STRUCTURE OF HUMAN SHIP2 PHOSPHATASE-C2 D607A MUTANT
588, d4p1xF_, 0.5395, 3.23, 0.094, 140, 117, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
589, d4p1xG_, 0.5392, 3.67, 0.094, 148, 117, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
590, p4ajwA1, 0.5392, 3.26, 0.094, 133, 117, DISCOVERY AND OPTIMIZATION OF NEW BENZIMIDAZOLE- AND BENZOXAZOLE- PYRIMIDONE SELECTIVE PI3KBETA INHIBITORS FOR THE TREATMENT OF PHOSPHATASE AND TENSIN HOMOLOGUE (PTEN)-DEFICIENT CANCERS
591, d2qk7B_, 0.5365, 3.16, 0.115, 123, 104, A COVALENT S-F HETERODIMER OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN
592, d5k59B_, 0.5321, 3.09, 0.163, 381, 104, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
593, d3m4eE_, 0.5257, 2.98, 0.215, 139, 107, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
594, d4iyaA_, 0.5254, 3.12, 0.062, 126, 112, STRUCTURE OF THE Y250A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
595, d3anzZ1, 0.5252, 3.87, 0.074, 215, 121, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
596, d3anzE1, 0.5248, 3.87, 0.074, 215, 121, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
597, d3anzB1, 0.5248, 2.68, 0.106, 125, 104, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
598, d3anzU1, 0.5247, 2.68, 0.106, 125, 104, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
599, d3anzM1, 0.5247, 3.73, 0.076, 211, 118, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
600, d3anzV1, 0.5245, 2.23, 0.277, 110, 94, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
601, d3anzO1, 0.5243, 3.81, 0.099, 235, 121, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
602, d3anzR1, 0.5242, 3.81, 0.099, 235, 121, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
603, d3m4eG_, 0.5239, 3.34, 0.162, 345, 105, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
604, d3m4dE_, 0.5239, 3.99, 0.107, 210, 121, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
605, d7ahlF_, 0.5238, 3.99, 0.107, 210, 121, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
606, d3m4eA_, 0.5238, 3.96, 0.084, 136, 119, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
607, d3m3rF_, 0.5235, 2.88, 0.149, 118, 94, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
608, d7ahlA_, 0.5234, 3.77, 0.051, 141, 117, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
609, d3m4eD_, 0.5233, 3.96, 0.059, 141, 118, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
610, d3m4dB_, 0.5230, 3.96, 0.059, 141, 118, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
611, d3anzY1, 0.5230, 3.95, 0.051, 141, 118, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
612, d4j0oB_, 0.5223, 3.79, 0.052, 141, 116, STRUCTURE OF THE Y246A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
613, d3m4dG_, 0.5222, 3.95, 0.059, 141, 118, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
614, p3anza2, 0.5222, 3.95, 0.051, 141, 118, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
615, d2enjA1, 0.5222, 3.99, 0.059, 141, 118, SOLUTION STURCTURE OF THE C2 DOMAIN FROM HUMAN PROTEIN KINASE C THETA
616, d3m4dD_, 0.5220, 3.80, 0.043, 141, 116, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
617, d7ahlD_, 0.5219, 3.96, 0.051, 140, 118, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
618, d4tw1I_, 0.5216, 3.97, 0.051, 140, 118, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
619, d3m4dA_, 0.5216, 3.81, 0.043, 141, 116, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
620, p3anzb2, 0.5213, 3.83, 0.043, 139, 116, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
621, d4u6vB_, 0.5209, 4.02, 0.051, 140, 117, MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY
622, d4u6vA_, 0.5202, 3.96, 0.052, 138, 116, MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY
623, d3m4eC_, 0.5202, 3.78, 0.044, 138, 114, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
624, d3m3rD_, 0.5202, 4.12, 0.051, 139, 118, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
625, d4tw1B_, 0.5195, 4.05, 0.043, 138, 117, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
626, d3m4dC_, 0.5194, 3.98, 0.052, 138, 116, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
627, d4iytA_, 0.5193, 3.99, 0.052, 138, 116, STRUCTURE OF THE Y184A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
628, d4iycB_, 0.5192, 4.05, 0.051, 138, 117, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
629, d4j0oC_, 0.5191, 3.95, 0.052, 137, 115, STRUCTURE OF THE Y246A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
630, d1t5rB_, 0.5190, 3.81, 0.044, 138, 113, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
631, d4izlB_, 0.5188, 4.00, 0.052, 138, 116, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
632, d1t5rF_, 0.5186, 3.77, 0.048, 292, 105, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
633, d1t5rE_, 0.5186, 3.09, 0.108, 120, 93, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
634, d3m2lC_, 0.5185, 3.09, 0.108, 120, 93, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
635, d1t5rG_, 0.5184, 3.25, 0.104, 105, 96, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
636, d1lkfA_, 0.5180, 3.25, 0.104, 105, 96, LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS
637, d4p24G_, 0.5178, 3.83, 0.048, 290, 104, PORE FORMING TOXIN
638, d3m3rC_, 0.5177, 4.05, 0.047, 290, 106, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
639, d3m4eF_, 0.5174, 3.91, 0.067, 257, 104, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
640, d3lkfA_, 0.5174, 3.97, 0.067, 266, 104, LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS WITH PHOSPHOCHOLINE BOUND
641, d4p1xA_, 0.5170, 3.92, 0.067, 257, 104, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
642, d4iycC_, 0.5170, 4.01, 0.048, 283, 104, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
643, d7ahlC_, 0.5169, 3.97, 0.067, 267, 104, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
644, d4yhdA1, 0.5168, 3.97, 0.067, 267, 104, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
645, d3anzP1, 0.5168, 3.80, 0.068, 257, 103, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
646, d3anzJ1, 0.5168, 3.98, 0.067, 266, 104, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
647, d3anzX1, 0.5167, 3.80, 0.068, 257, 103, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
648, d3anzQ1, 0.5167, 3.98, 0.067, 267, 104, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
649, d4yhdG_, 0.5166, 3.71, 0.079, 298, 101, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
650, d3m4dF_, 0.5164, 4.30, 0.083, 276, 108, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
651, d3anzN1, 0.5164, 4.31, 0.083, 288, 108, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
652, d3anzF1, 0.5164, 4.31, 0.083, 275, 108, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
653, d4yhdC1, 0.5163, 2.93, 0.053, 104, 94, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
654, d3anzL1, 0.5163, 3.71, 0.069, 255, 101, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
655, d3anzA1, 0.5163, 3.63, 0.120, 266, 100, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
656, d3anzK1, 0.5161, 3.18, 0.154, 322, 91, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
657, d3anzD1, 0.5160, 3.81, 0.119, 287, 101, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
658, d4p24F_, 0.5158, 4.24, 0.095, 293, 105, PORE FORMING TOXIN
659, d2lkfA_, 0.5158, 4.24, 0.095, 293, 105, LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS
660, d4p1yE_, 0.5156, 3.79, 0.090, 293, 100, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
661, d3m2lD_, 0.5155, 4.03, 0.059, 283, 102, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
662, d3m2lB_, 0.5152, 4.03, 0.059, 283, 102, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
663, d3m3rA_, 0.5151, 3.84, 0.090, 293, 100, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
664, d4izlC_, 0.5150, 3.83, 0.090, 293, 100, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
665, d3m2lF_, 0.5149, 3.85, 0.090, 293, 100, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
666, d4yhdB1, 0.5147, 3.86, 0.090, 293, 100, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
667, d4j0oA_, 0.5145, 3.84, 0.090, 293, 100, STRUCTURE OF THE Y246A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
668, d4j0oD_, 0.5140, 3.85, 0.090, 293, 100, STRUCTURE OF THE Y246A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
669, d1t5rA_, 0.5130, 3.85, 0.090, 293, 100, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
670, d4iycA_, 0.5124, 3.85, 0.090, 293, 100, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
671, d1t5rD_, 0.5124, 3.84, 0.090, 293, 100, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
672, d4q7gA_, 0.5123, 3.82, 0.090, 293, 100, 1.7 ANGSTROM CRYSTAL STRUCTURE OF LEUKOTOXIN LUKD FROM STAPHYLOCOCCUS AUREUS.
673, p3rohA_, 0.5121, 3.82, 0.090, 293, 100, CRYSTAL STRUCTURE OF LEUKOTOXIN (LUKE) FROM STAPHYLOCOCCUS AUREUS SUBSP. AUREUS COL.
674, d4izlA_, 0.5119, 3.83, 0.090, 293, 100, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
675, d1t5rC_, 0.5118, 3.85, 0.090, 293, 100, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
676, p4idjA_, 0.5117, 3.84, 0.090, 293, 100, S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB
677, d4izlD_, 0.5115, 3.82, 0.090, 293, 100, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
678, d4iycD_, 0.5115, 3.84, 0.090, 293, 100, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
679, d1t5rH_, 0.5111, 3.86, 0.090, 293, 100, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
680, d4yhdD1, 0.5107, 4.04, 0.059, 277, 102, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
681, d2qk7A_, 0.5089, 3.86, 0.090, 293, 100, A COVALENT S-F HETERODIMER OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN
682, d4yhdE_, 0.5081, 4.09, 0.089, 243, 101, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
683, d3anzT1, 0.5054, 3.74, 0.115, 125, 104, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
684, d7ahlG_, 0.5014, 3.74, 0.115, 125, 104, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
685, d7ahlE_, 0.5013, 3.85, 0.090, 293, 100, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
686, d3m4eB_, 0.5011, 3.85, 0.090, 293, 100, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
687, d3m2lE_, 0.5009, 4.40, 0.095, 290, 105, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
688, d3m3rE_, 0.5005, 3.85, 0.090, 293, 100, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
689, p5dmyA1, 0.5002, 4.11, 0.089, 244, 101, BETA-GALACTOSIDASE - CONSTRUCT 33-930
